JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 12.36% |
| 3 | Healthcare | 9.31% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
iShares MSCI Qatar ETF
QAT
$63.5M
| $411K | ﹤0.01% |
22,953
+2,003
| +10% | +$36.6K |
|
4152
Bristow Group
VTOL
$1.36B
| $411K | ﹤0.01% |
24,082
-2,009
| -8% | -$35.9K |
|
|
DBVT
4153
DBV Technologies
DBVT
$889M
| $409K | ﹤0.01% |
5,133
-1,820
| -26% | -$163K |
|
4154
NVE Corp
NVEC
$591M
| $409K | ﹤0.01% |
5,823
+4,659
| +400% | +$388K |
|
|
FSB
4155
DELISTED
Franklin Financial Network, Inc.
FSB
| $409K | ﹤0.01% |
14,802
+82
| +0.6% | +$2.28K |
|
4156
Kearny Financial
KRNY
$604M
| $408K | ﹤0.01% |
31,113
+3,693
| +13% | +$49.7K |
|
4157
Natural Health Trends
NHTC
$15.4M
| $407K | ﹤0.01% |
52,289
+50,492
| +2,810% | +$528K |
|
|
XNET
4158
Xunlei
XNET
$316M
| $407K | ﹤0.01% |
+162,901
| New | +$502K |
|
|
PDLI
4159
DELISTED
PDL BioPharma, Inc.
PDLI
| $405K | ﹤0.01% |
132,775
+5,257
| +4% | +$17.1K |
|
4160
NCS Multistage Holdings
NCSM
$134M
| $404K | ﹤0.01% |
5,439
-3,366
| -38% | -$251K |
|
4161
Hovnanian Enterprises
HOV
$793M
| $403K | ﹤0.01% |
55,917
+52,730
| +1,655% | +$639K |
|
|
AIG.WS
4162
DELISTED
American International Group, Inc.
AIG.WS
| – | – |
0
| – | – |
|
4163
FRP Holdings
FRPH
$425M
| $400K | ﹤0.01% |
15,940
-130
| -0.8% | -$3.21K |
|
4164
Tejon Ranch
TRC
$441M
| $400K | ﹤0.01% |
24,252
+18,876
| +351% | +$322K |
|
|
CSII
4165
DELISTED
Cardiovascular Systems, Inc.
CSII
| $400K | ﹤0.01% |
9,381
+1,151
| +14% | +$44.7K |
|
4166
Kinetik
KNTK
$4.12B
| $398K | ﹤0.01% |
11,053
+10,614
| +2,418% | +$528K |
|
4167
Bankwell Financial Group
BWFG
$542M
| $392K | ﹤0.01% |
13,619
-603
| -4% | -$17.7K |
|
4168
Global X FinTech ETF
FINX
$173M
| $392K | ﹤0.01% |
+13,353
| New | +$381K |
|
4169
Regis Corp
RGS
$69.3M
| $392K | ﹤0.01% |
1,174
+247
| +27% | +$93.6K |
|
4170
BlackRock TCP Capital
TCPC
$353M
| $392K | ﹤0.01% |
27,782
-10,539
| -28% | -$152K |
|
|
ZVO
4171
DELISTED
Zovio Inc. Common Stock
ZVO
| $392K | ﹤0.01% |
113,925
+73,464
| +182% | +$366K |
|
4172
Shutterstock
SSTK
$217M
| $390K | ﹤0.01% |
10,031
+2,008
| +25% | +$83.3K |
|
|
INFN
4173
DELISTED
Infinera Corporation Common Stock
INFN
| $389K | ﹤0.01% |
133,370
-2,713,614
| -95% | -$10.2M |
|
|
DS
4174
DELISTED
Drive Shack Inc.
DS
| $388K | ﹤0.01% |
83,433
-6,715
| -7% | -$32.6K |
|
|
GBL
4175
DELISTED
GAMCO Investors, Inc.
GBL
| $388K | ﹤0.01% |
21,170
-2,126
| -9% | -$41.8K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.